Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PI3K/Akt/mTOR Signaling Pathway as a Target for Colorectal Cancer Treatment
Premila D. Leiphrakpam, Chandrakanth Are
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3178-3178
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

An immunohistochemical and molecular genetic study of 60 colorectal carcinoma brain metastases in pursuit of predictive biomarkers for cancer therapy
Jerzy Lasota, Maciej Kaczorowski, Małgorzata Chłopek, et al.
Human Pathology (2025) Vol. 155, pp. 105717-105717
Closed Access | Times Cited: 1
METTL1 Enhances RRP9 mRNA Stability Through m7G Modification to Drive Colorectal Tumorigenesis
Nan Li, Ying Jing, Long Xu, et al.
Molecular Carcinogenesis (2025)
Closed Access | Times Cited: 1
Nanomedicine innovations in colon and rectal cancer: advances in targeted drug and gene delivery systems
Sobia Razzaq, Iqra Fatima, Zeinab Moafian, et al.
Medical Oncology (2025) Vol. 42, Iss. 4
Closed Access | Times Cited: 1
Genetic Insights into Colorectal Cancer: Evaluating PI3K/AKT Signaling Pathway Genes Expression
Rafał Świechowski, Jacek Pietrzak, Agnieszka Wosiak, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5806-5806
Open Access | Times Cited: 6
PAMAM/miR-144 Nanocarrier System Inhibits the Migration of Gastric Cancer by Targeting mTOR Signal Transduction Pathway
Yuanyuan Qian, Dongxu Zhu, XU Qiong, et al.
Colloids and Surfaces B Biointerfaces (2025) Vol. 249, pp. 114492-114492
Closed Access
Reverse-engineering the FLT3-PI3K/AKT axis to enhance TILs function and improve prognosis in ovarian and cervical cancers
Hao Feng, Yan Zhang, Lili Shen, et al.
Journal of Ovarian Research (2025) Vol. 18, Iss. 1
Open Access
Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer
Jennifer Haynes, Prasath Manogaran
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1988-1988
Open Access
Current advancement of immune function paradox of tumour-infiltrating cells and their immunotherapeutic targets: a mini-review
VEENA V. TOM, A. De la Fuente Hernández José, Sumit Mallick, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Advances in the Design, Discovery, and optimization of aurora kinase inhibitors as anticancer agents
Anita Verma, Pradhuman Bharatiya, Aashish Jaitak, et al.
Expert Opinion on Drug Discovery (2025)
Closed Access
Metabolomics- and Proteomics-Based Disease Diagnostic Classifier Model for the Prediction and Diagnosis of Colorectal Carcinoma
Zhaorui Wang, Tianyuan Li, Mengyao Sun, et al.
Journal of Proteome Research (2025)
Closed Access
Prognostic gene expression profile of colorectal cancer
Mohamed J. Saadh, Omer Qutaiba B. Allela, Radhwan Abdul Kareem, et al.
Gene (2025), pp. 149433-149433
Closed Access
Insights into the Therapeutic Targets and Molecular Mechanisms of Eruca sativa Against Colorectal Cancer: An Integrated Approach Combining Network Pharmacology, Molecular Docking and Dynamics Simulation
Humera Banu, Eyad Al-Shammari, Syed Shahanawaz, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 453-453
Open Access
Ethnicity-Specific Molecular Alterations in MAPK and JAK/STAT Pathways in Early-Onset Colorectal Cancer
Cecilia Monge, Brigette Waldrup, Francisco Carranza, et al.
Cancers (2025) Vol. 17, Iss. 7, pp. 1093-1093
Open Access
Warhead-bearing natural compounds for multi-pathway irreversible inhibition to overcome drug resistance in colorectal cancer
Hua-ping Hou, Xinqi Liu, Wentao Liu, et al.
Medical Oncology (2025) Vol. 42, Iss. 5
Closed Access
Demystifying the Role of Histone Demethylases in Colorectal Cancer: Mechanisms and Therapeutic Opportunities
Yuanbin Liu, Min Huang, Tian Xia, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 4, pp. 267-267
Open Access
Reserpine Ameliorates 1,2-Dimethylhydrazine-induced Colon Cancer Through Regulating Xenobiotic Enzymes and Bax/Caspases/Bcl-2-mediated Apoptotic Mechanisms in Rats
Wenli He, Lina He
Pharmacognosy Magazine (2025)
Closed Access
Discovery of tetracyclic 1,2,4-triazoline-fused dibenzo[b,f][1,4]oxazepine as a potent anti-colorectal cancer agent with good efficacy and low toxicity
Qiwen Shi, Tao Zhou, Yanting Zhou, et al.
Bioorganic & Medicinal Chemistry (2025) Vol. 125, pp. 118203-118203
Closed Access
Integrative Multi-omics and Supervised Learning Identifies an Epithelial Signature for Radiotherapy Response in Colorectal Cancer
Rahul Kumar, Jiarui Zhou, Andrew D. Beggs, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
The E3 Ligase NEDD4L Prevents Colorectal Cancer Liver Metastasis via Degradation of PRMT5 to Inhibit the AKT/mTOR Signaling Pathway
Zhewen Dong, Xiaofei She, Junxian Ma, et al.
Advanced Science (2025)
Open Access
Rapamycin circumvents anti PD-1 therapy resistance in colorectal cancer by reducing PD-L1 expression and optimizing the tumor microenvironment
Menglei Jia, Zhongwen Yuan, Hang Yu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116883-116883
Open Access | Times Cited: 3
Nano‐Titanium Oxide‐Coated Carbon Nanotubes for Photothermal Therapy in the Treatment of Colorectal Cancer
Jun Xie, Da Li, Sen Niu, et al.
Advanced Healthcare Materials (2024)
Closed Access | Times Cited: 3
Fucoxanthin Inhibits the Proliferation and Metastasis of Human Pharyngeal Squamous Cell Carcinoma by Regulating the PI3K/Akt/mTOR Signaling Pathway
Hao-Fei Du, Jia-Min Jiang, Sihan Wu, et al.
Molecules (2024) Vol. 29, Iss. 15, pp. 3603-3603
Open Access | Times Cited: 3
Emerging roles of non-coding RNAs in modulating the PI3K/Akt pathway in cancer
Mehrdad Hashemi, Elaheh Mohandesi Khosroshahi, Saba Asadi, et al.
Non-coding RNA Research (2024) Vol. 10, pp. 1-15
Open Access | Times Cited: 3
KIFC3 promotes the progression of non–small cell lung cancer cells through the PI3K/Akt pathway
Yu Mu, Haoxiang Liu, Anni Luo, et al.
Thoracic Cancer (2024) Vol. 15, Iss. 33, pp. 2356-2364
Open Access | Times Cited: 3
Effect and mechanism of Magnolia officinalis in colorectal cancer: multi-component-multi-target approach
He Zhang, Jun Tang, Huiliang Cao, et al.
Journal of Ethnopharmacology (2024), pp. 119007-119007
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top